Diploma (LON:DPLM – Get Free Report) had its price objective raised by equities research analysts at JPMorgan Chase & Co. from GBX 5,760 to GBX 8,250 in a research note issued on Monday,London Stock Exchange reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 13.25% from the company’s previous close.
Other research analysts have also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft increased their price target on shares of Diploma from GBX 6,400 to GBX 7,200 and gave the stock a “buy” rating in a report on Wednesday, May 20th. Royal Bank Of Canada boosted their target price on Diploma from GBX 7,300 to GBX 7,400 and gave the stock an “outperform” rating in a research report on Friday, July 17th. Jefferies Financial Group restated a “hold” rating and issued a GBX 7,000 price target on shares of Diploma in a research report on Friday, May 29th. Finally, Berenberg Bank reaffirmed a “buy” rating and set a GBX 9,000 price target on shares of Diploma in a research note on Monday, July 20th. Six analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 7,400.
View Our Latest Analysis on Diploma
Diploma Trading Up 1.5%
Insider Transactions at Diploma
In related news, insider Mandy Gradden acquired 1,000 shares of Diploma stock in a transaction dated Friday, July 17th. The shares were acquired at an average cost of GBX 7,183 per share, for a total transaction of £71,830. Also, insider Katie Bickerstaffe acquired 133 shares of the company’s stock in a transaction that occurred on Thursday, July 16th. The shares were bought at an average price of GBX 7,048 per share, with a total value of £9,373.84. Insiders purchased a total of 1,604 shares of company stock valued at $11,447,718 over the last three months. 1.14% of the stock is currently owned by insiders.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
- Five stocks we like better than Diploma
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
